A phase 2, open-label study of anti-inflammatory NE3107 in patients with dementias.
Haroon J, Jordan K, Mahdavi K, Rindner E, Becerra S, Surya JR, Zielinski M, Venkatraman V, Goodenowe D, Hofmeister K, Zhang J, Ahlem C, Reading C, Palumbo J, Pourat B, Kuhn T, Jordan S.
Haroon J, et al.
Medicine (Baltimore). 2024 Jul 26;103(30):e39027. doi: 10.1097/MD.0000000000039027.
Medicine (Baltimore). 2024.
PMID: 39058809
Free PMC article.
Clinical Trial.